Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
ModivCare
MODV
ModivCare
Medicare Reimbursement Cuts And Digital Rivals Will Weaken Revenues
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
14 Aug 25
Updated
14 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$1.20
10.8% undervalued
intrinsic discount
14 Aug
US$1.07
Loading
1Y
-96.0%
7D
-54.5%
Author's Valuation
US$1.2
10.8% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$1.2
10.8% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-230m
3b
2014
2017
2020
2023
2025
2026
2028
Revenue US$3.0b
Earnings US$159.7m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
1.05%
Healthcare Services revenue growth rate
0.26%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
12.32%
Calculation
US$159.74m
Earnings '28
x
0.16x
PE Ratio '28
=
US$25.00m
Market Cap '28
US$25.00m
Market Cap '28
/
14.70m
No. shares '28
=
US$1.70
Share Price '28
US$1.70
Share Price '28
Discounted to 2025 @ 12.32% p.a.
=
US$1.20
Fair Value '25
